ClinicalTrialsFinder

Anaplastic Large Cell Lymphoma, ALK-Positive Clinical Trials in Paris

1 recruitingParis, France

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors

Anaplastic Large Cell Lymphoma, ALK-PositiveInflammatory Myofibroblastic TumorOther Solid Tumor
Princess Maxima Center for Pediatric Oncology65 enrolled2 locationsNCT04925609